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ABSTRACT Normal somatic cells invariably enter a state
of irreversibly arrested growth and altered function after a
finite number of divisions. This process, termed replicative
senescence, is thought to be a tumor-suppressive mechanism
and an underlying cause of aging. There is ample evidence that
escape from senescence, or immortality, is important for
malignant transformation. By contrast, the role of replicative
senescence in organismic aging is controversial. Studies on
cells cultured from donors of different ages, genetic back-
grounds, or species suggest that senescence occurs in vivo and
that organismic lifespan and cell replicative lifespan are under
common genetic control. However, senescent cells cannot be
distinguished from quiescent or terminally differentiated cells
in tissues. Thus, evidence that senescent cells exist and
accumulate with age in vivo is lacking. We show that several
human cells express a f3-galactosidase, histochemically de-
tectable at pH 6, upon senescence in culture. This marker was
expressed by senescent, but not presenescent, fibroblasts and
keratinocytes but was absent from quiescent fibroblasts and
terminally differentiated keratinocytes. It was also absent
from immortal cells but was induced by genetic manipulations
that reversed immortality. In skin samples from human
donors of different age, there was an age-dependent increase
in this marker in dermal fibroblasts and epidermal kerati-
nocytes. This marker provides in situ evidence that senescent
cells may exist and accumulate with age in vivo.
Normal, somatic cells do not divide indefinitely. This property,
termed the finite replicative lifespan of cells, leads to an
eventual arrest of cell division by a process termed replicative
or cell senescence. Replicative senescence is generally studied
in culture, where cells can be grown and monitored-in a
controlled fashion-until most or all cells in a population
senesce (1-4). Indirect evidence suggests that replicative se-
nescence occurs in vivo (see refs. 2 and 4).
There are several salient features of senescence in culture
(2-4). (i) It is exceedingly stringent in human cells, which,
unlike many rodent cells, rarely if ever spontaneously immor-
talize. (ii) Senescent cells arrest growth with a GI DNA content
and do not enter S phase in response to physiologic mitogens.
Many genes remain mitogen-inducible, but some that are
needed for cell cycle progression are repressed. (iii) Multiple,
dominant-acting genes control the finite replicative lifespan
and growth arrest of senescent cells. (iv) Senescent cells show
selected, cell-specific changes in function. (v) Senescent cells
remain metabolically active, and resist apoptotic death, for
long periods of time.
The idea that cellular senescence is tumor suppressive stems
from molecular, cellular, and in vivo data. Immortality greatly
increases the susceptibility to malignant transformation, in
culture and in vivo (5, 6). Indeed, many tumors contain
immortal cells or cells with an extended replicative lifespan (7).
In addition, some oncogenes act primarily to immortalize or
extend the lifespan of cells. Finally, Rb and p53, tumor
suppressors that commonly suffer loss-of-function mutations
in human cancers, are critical for cell senescence (see refs. 4
and 8).
The idea that senescence contributes to aging, by contrast,
stems largely from studies in culture. Cells cultured from old
donors tend to senesce after fewer population doublings (PD)
than cells from young donors (9-11). Thus, cells in renewable
tissues may deplete their replicative potential during aging.
Moreover, cells from short-lived species tend to senesce after
fewer PD than cells from long-lived species (11, 12), and cells
from humans with hereditary premature aging syndromes
senesce more rapidly than age-matched controls (13, 14). Thus,
cellular replicative lifespan and organismic lifespan may be
under overlapping genetic control. Together, the data support
the idea that replicative senescence occurs in vivo. It is assumed
that senescent cells accumulate in vivo, where their altered
phenotype contributes to age-related pathology.
Senescent cells are identified in culture by their failure to
synthesize DNA under optimal conditions and exponential
increase with passage. In vivo, however, cell growth is not easily
manipulated or monitored, and DNA synthesis measurements
do not distinguish senescent cells from quiescent or terminally
differentiated cells. Senescence markers identified in culture
(2-4) either are not specific or require single cell quantitation
or manipulations (e.g., mitogen stimulation) that are difficult
to do or control in vivo. Thus, the idea that senescent cells
accumulate with age has remained speculative because senes-
cent cells cannot be identified in tissues.
We describe a simple biomarker for replicative senescence
that provides in situ evidence that senescent cells may persist
and accumulate with age in vivo.
MATERIALS AND METHODS
Cells. WI-38, AG09602, AG06234, AG07720, AG0439,
AG00780, and AG06300 were from the Coriell Institute
(Camden, NJ). HCA2, HT1080, HeLa, TE85, and CMV-MJ
were from O.P.-S., and 88-6 and MC17326 were from J.
Oshima and G. Martin (University of Washington, Seattle).
Abbreviations: PD, population doublings; NHEK, neonatal human
epidermal keratinocytes; dex, dexamethasone; X3-Gal, f3-galactosidase;
SA-,B-Gal, senescence-associated ,B-Gal.
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Cells were cultured, as described (15-17). Neonatal human
epidermal keratinocytes (NHEK; Clonetics, San Diego) were
cultured as per the supplier's instructions in 10% CO2 and 10
mM Hepes (pH 7.4); differentiation was induced by CaCl2 or
phorbol 12-myristate 13-acetate (18). Microcell fusion was
performed, as described (16, 17). IDH4 cells were grown in 1
,tM dexamethasone (dex) or arrested in 10% charcoal-stripped
serum and medium lacking phenol red and dex, as described
(19). Human endothelial cells (strain H3605) were from J.
Wessendorf and T. Maciag (American Red Cross, Rockville,
MD) (20), neonatal melanocytes were from Z. Abdel-Malek
(University of Cincinnati), adult melanocytes were from shave
biopsies (21), mammary cells were from V. Band (New En-
gland Medical Center, Boston) (22), and ovarian cells were
from N. Auersperg (23). SV40-WI38, C33a, U20S, SAOS, and
HTB9 were from the American Type Culture Collection.
[3HJThymidine Labeling. Sparse cells (1-5 x 103 per cm2)
were given 10 ,uCi of [3H]thymidine (60-80 Ci/mmol; 1 Ci =
37 GBq) per ml for 48-72 hr, stained where indicated, washed
in phosphate-buffered saline (PBS), rinsed twice in methanol,
and processed for autoradiography, as described (15).
I8-Galactosidase (13-Gal) Staining. Cells were washed in
PBS, fixed for 3-5 min (room temperature) in 2% formalde-
hyde/0.2% glutaraldehyde (or 3% formaldehyde), washed,
and incubated at 37°C (no C02) with fresh senescence-
associated (3-Gal (SA-,3-Gal) stain solution: 1 mg of 5-bromo-
4-chloro-3-indolyl P3-D-galactoside (X-Gal) per ml (stock = 20
mg of dimethylformamide per ml)/40 mM citric acid/sodium
phosphate, pH 6.0/5 mM potassium ferrocyanide/5 mM po-
tassium ferricyanide/150 mM NaCl/2 mM MgCl2. Staining
was evident in 2-4 hr and maximal in 12-16 hr. To detect
lysosomal ,B-Gal, the citric acid/sodium phosphate was pH 4.0.
Skin Samples. Human skin from individuals undergoing
Moh's micrographic surgery for skin cancer was rapidly frozen
in liquid nitrogen, and mounted in OCT. Thin sections (4 ,um)
were cut, mounted onto glass slides, fixed in 1% formalin in
PBS for 1 min at room temperature, washed in PBS, immersed
overnight in SA-3-Gal staining solution, counterstained with
eosin, and viewed under bright field at 100-200X magnifica-
tion.
RESULTS
13-Gal in Cultured Human Fibroblasts. Senescent human
fibroblasts expressed a 13-Gal that was detected in single cells
by X-Gal, which forms a local blue precipitate upon cleavage
(24), independent of DNA synthesis measurements. Early,
middle, and late passage cultures (15) were given [3H]thymi-
dine to label presenescent cells, stained for }3-Gal, and pro-
cessed for autoradiography. Thus, individual cells were mon-
itored simultaneously for ability to synthesize DNA and (3-Gal
activity. Two human fibroblast strains, HCA2 (neonatal fore-
skin) and WI-38 (fetal lung), showed similar results.
Most cells express a lysosomal (3-Gal that is optimally active
at about pH 4 (25). Indeed, presenescent and senescent cells
stained equally well when assayed at pH 4 (Fig. 1 A and B).
Neither stained at pH 7.5, the optimum for the bacterial (3-Gal
reporter enzyme (not shown). At pH 6, only senescent cells
stained (Fig. 1 C and D). We refer to this pH 6 activity as the
SA-1-Gal.
Most early passage cells were labeled with [3H]thymidine
and did not express SA-f3-Gal (Fig. 1C). The occasional
SA-13-Gal-positive cell almost invariably was unlabeled (Fig.
1C). With increasing PD, there was a striking inverse relation-
ship between SA-13-Gal staining and radiolabeling (Fig. 2A).
By late passage, most cells were unlabeled and strongly SA-
P-Gal positive (Fig. 1D). The most intense staining was
perinuclear and in late passage cultures (Fig. 1D). Upon
replating, senescent cells retained SA-1-Gal and did not divide
(not shown). Typically, radiolabeled cells were SA-1-Gal neg-
FIG. 1. 83-Gal in cultured human cells. Cells were radiolabeled,
stained, and photographed at 10OX (A-E and J-L) or 200X (F-I)
magnification (final magnifications: A-E and J-L, x60; F-I, x 120).
Most cells were either labeled and SA-,B-Gal negative or unlabeled and
SA-f-Gal positive. Double positive cells comprised <0.1% of early,
and 5-8% of late, passage cultures. Such cells may have completed
their last cell cycle and induced SA-,B-Gal during the 3-day labeling or
induced SA-13-Gal before the last cell cycle. Double negatives com-
prised 1-2% of early, and 20-25% of late, passage cultures. Some were
slow-cycling cells, because labeling for 5-7 days reduced them from
22% to 16% and increased labeled cells from 15% to 20%. Others
expressed low SA-,3-Gal, since longer staining (24 vs. 8 hr) decreased
them from 23% to 17% and increased SA-f3-Gal positives from 69%
to 75%. Ten to 15% of cells in senescent cultures were unlabeled and
SA-f-Gal negative for unknown reasons. (A and B) Early passage (A)
and senescent (B) WI-38 cells stained for lysosomal 1B-Gal. (C) Early
passage HCA2 cells; labeled, SA-3-Gal staining. An unlabeled SA-
13-Gal-positive cell is in the lower right. (D) Senescent HCA2; labeled,
SA-,B-Gal staining. A labeled SA-,B-Gal-negative cell is in upper left.
(E) Presenescent, confluent WI-38; SA-,3-Gal staining. Staining dis-
appeared 2 days after replating. (F) Early passage NHEK; labeled,
SA-P-Gal staining. (G) Middle passage NHEK; labeled, SA-,3-Gal
staining. (H) Early passage differentiated NHEK; labeled, SA-P3-Gal
staining. (I) CMV-MJ cells 10 passages after receiving human chro-
mosome 1; labeled, SA-,B-Gal staining. Unlabeled SA-,B-Gal-positive
cells were not seen in the parent culture. (J) IDH4 cells growing in dex;
SA-13-Gal staining. (K) IDH4 minus dex for 17 days; SA-,B-Gal
staining. (L) IDH4 minus dex for 20 days, then plus dex for 3 days;
SA-13-Gal staining.
ative, and unlabeled cells were SA-,B-Gal positive (see legend
to Fig. 1).
SA-13-Gal Is Not Induced Quiescence or Terminal Differ-
entiation. Presenescent fibroblasts were made quiescent by
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FIG. 2. SA-j-Gal and replicative capacity in culture. Cells were
radiolabeled for 72 hr and stained, and 100-500 cells were scored for
labeled nuclei and SA-,B-Gal staining. (A) SA-f3-Gal and replicative
capacity during serial passage. Open symbols, WI-38 cells; closed
symbols, HCA2 cells. (B) SA-,B-Gal, replicative capacity, and donor
age. The name, genotype, donor age, and percent labeled nuclei of five
normal (N) and three Werner (W) skin fibroblast cultures are as
follows: AG07720, N, 24 yr, 75%; AG0439, N, 73 yr, 30%; AG06234,
N, 17 yr, 15%; AG09602, N, 92 yr, 60%; 88-6, N, 52 yr, 10%; AG00780,
W, 59 yr, 50%; AG06300, W, 36 yr, 38%; MC17326, W, 57 yr, 8%.
serum deprivation. Growth declined markedly over 3 days, but
SA-,B-Gal was not induced, even after 7 days (Table 1). Similar
results were obtained with cells made quiescent by confluence,
except that positive staining was evident where cells were
dense and overlapped (Fig. 1E). This staining was generally
less intense than that seen in senescent cells and was lost within
2 days of replating.
Early passage human keratinocytes (NHEK) were also
largely SA-13-Gal negative (Fig. 1F; Table 1) but stained for
lysosomal 13-Gal (not shown). After 8-10 PD, [3H]thymidine
labeling declined, and unlabeled SA-P-Gal-positive cells rose
(Fig. 1G; Table 1). Thus, senescence and SA-13-Gal were also
linked in keratinocytes. Moreover, early passage terminally
differentiated NHEK did not express SA-f-Gal, despite a
decline in proliferation (Fig. 1H; Table 1).
SA-%8-Gal Correlates with Replicative Age. Skin fibroblasts
from two young and two old adult donors were tested for
SA-,B-gal and replicative capacity. Each culture had undergone
15-20 PD when tested. Two had replicative potentials typical
of their age (9-11), and two were unusual in this regard. In all
cases, SA-P3-Gal varied inversely with replicative age, not
donor age (Fig. 2B). We also tested skin fibroblasts from
donors with the Werner syndrome, a hereditary disorder
showing accelerated aging in vivo and accelerated senescence
in culture (13, 14, 26). Werner syndrome cultures accumulated
SA-f3-Gal-positive cells coincident with the loss of replicative
capacity (Fig. 2B). Thus, SA-,B-Gal reflected the replicative or
physiologic age of cells, not necessarily the chronological age
of the donor.
SA-8-Gal in Other Cell Types. SA-,B-Gal and replicative
senescence were correlated in several other cell types. Human
umbilical vein endothelial cultures at early passage (65%
labeled) had few SA-13-Gal-positive cells (11%), but positive
cells increased (32% and 45%) at later passages (36% and 24%
labeled). SA-03-Gal also correlated with replicative capacity in
human mammary epithelial cells, rising from 2% at early
passage to 30% at middle passage. Finally, neonatal human
melanocytes were <1% SA-,B-Gal positive at early passage but
>90% positive at senescence. An exception was melanocytes
from adult donors. Early passage adult melanocytes grew well
in culture, yet >90% expressed pH 6 {3-Gal activity.
Immortal Cells Do Not Express SA-,8-Gal. SA-P3-Gal was
undetectable in immortal cells, including large tumor antigen
(T-antigen)-immortalized WI-38 cells and human carcinoma,
fibrosarcoma, and osteosarcoma cells (HT1080, HeLa, C33a,
U20S, SAOS, TE85, HTB9, CMV-MJ). These cultures were
>90% [3H]thymidine labeled and <0.1% SA-J3-Gal positive.
Genetic manipulations that induced immortal cells to se-
nesce induced SA-,B-Gal. Human chromosome 1 causes
CMV-MJ cells to senesce after 5-10 PD (17). Eight PD after
chromosome 1 was introduced into these cells, 39% were
SA-f3-Gal positive and mostly unlabeled (Fig. 11). Similar
results were obtained with HeLa cells, in which chromosome
4 causes senescence after very few doublings (16). Virtually all
cells in hybrid clones of <60 cells were SA-,B-Gal positive.
Chromosome 11 does not cause HeLa to senesce and did not
induce SA-13-Gal (not shown).
Simian virus 40 (SV40) T antigen extends replicative life-
span (4, 8, 21) and delayed SA-f3-Gal induction. Human
ovarian epithelial cells senesce after 6-8 passages, but SV40-
infected cultures proliferate for 20 passages (23). Normal
cultures at fourth passage were 20% [3H]thymidine labeled
and 80% (mostly unlabeled) SA-13-Gal positive; fourth passage
SV40-infected cultures were 80% labeled and 1% SA-3-Gal
positive (not shown). T-antigen-expressing cultures eventually
enter crisis, from which rare immortal cells emerge (8, 19).
Less than 1% of SV40-infected human fibroblasts expressed
SA-13-Gal prior to crisis, 95% were positive during crisis, and
<0.1% were positive after immortal cells overgrew the culture
(not shown). SA-f3-Gal was also examined in IDH4 human
fibroblasts, in which a dex-inducible T antigen reversibly
regulates senescence (19). IDH4 cells growing in dex were
<0.1% SA-f3-Gal positive. After dex withdrawal, growth
ceased and 88% of the cells expressed SA-,B-Gal. SA-,B-Gal
Table 1. Sa-,3-Gal in senescence, quiescence, and
terminal differentiation
% labeled % SA-f-Gal
Cells Passage condition nuclei positive
WI-38 Early/prolif 72 3
Early/quies, 3 days 9 2
Early/quies, 7 days 2 2
Middle-late/prolif 27 52
Middle-late/quies, 4 days 1 56
NHEK Early/prolif 77 <0.1
Early/diff (Ca, 4 days) 28 <0.1
Early/diff (PMA, 4 days) 21 3
Middle/prolif 53 23
Middle/diff (Ca, 5 days) 12 2
WI-38 cells growing in 10% serum (prolif) were radiolabeled for 72
hr and stained for SA-,B-Gal or were shifted to 0.2% serum for 3 or 7
days (quies) and stained, and parallel cultures were labeled for 48 hr
thereafter. NHEK in growth medium (prolif) were similarly labeled
and stained or were given 2 mM CaC12 (Ca) or 80 nM phorbol
12-myristate 13-acetate (PMA) for 4 or 5 days (diff), labeled for the
last 48 hr, and stained. For each determination, 100-500 cells were
counted.
Cell tiology: Dimri et al.
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declined to <0.1% when dex was resupplied and growth
resumed (Fig. 1 J-L).
SA-8-Gal in Human Skin. To explore the idea that senes-
cent cells accumulate in vivo, skin samples from 20 human
donors, aged 20-90 yr, were sectioned and stained for 13-Gal.
Most cells in the sections stained well for lysosomal 13-Gal (not
shown). SA-13-Gal-stained sections were examined blind by a
dermatological pathologist for the staining frequency and
identity of positive cells (Fig. 3; Table 2). Two staining patterns
were evident.
First, positive staining was always seen in the hair follicles,
and frequently in associated sebaceous glands (Fig. 3A), and in
eccrine glands and ducts (Fig. 3B). This staining was indepen-
dent of donor age. A second pattern was seen in the dermis and
epidermis (Fig. 3 C-H). This staining increased with age in
frequency and intensity (Table 2).
In the dermis, SA-13-Gal-positive cells were tentatively iden-
tified as fibroblasts, and they were sparsely and randomly
distributed. None of the young donors (<40 yr) showed dermal
staining. By contrast, all but one old (>69 yr) donor had
_ ;*+S~- ^51 B
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FIG. 3. SA-/3-Gal in human skin. Human skin samples were
sectioned, stained for SA-P-Gal, counterstained, and photographed at
100-400X magnification (final magnification given below). Sections
were scored blind for SA-,B-Gal frequency (Table 1). Scores for the
sections shown are given in parentheses. (A) Age-independent staining
in hair follicle and sebaceous gland. (x60; 38-yr-old female.) Note
dense dermal collagen typical of young skin and absence of staining
outside the follicle. (B) Age-independent staining in eccrine gland.
(x 120; 76-yr-old male.) (C) Young dermis and epidermis. (-, x120;
38-yr-old female.) (D) Young dermis and epidermis. (-, x 120;
38-yr-old female.) Note sun damage (basal epidermal cell melaniza-
tion) but absence of staining. (E) Old dermis. (+ +, x 120; 70-yr-old
male.) Staining in single cells, indicated by arrowheads, was present in
adjacent sections. (F) Old dermis. (+ + +, X240; 76-yr-old male.) (G)
Old epidermis. (+ +, x 120; 73-yr-old female.) (H) Old epidermis.
(+ + +, x 120; 73-yr-old male.)
Table 2. SA-/3-Gal activity in human skin from donors of
different age
SA-,B-Gal staining
Donor Age, yr Sex Site Epidermis Dermis
Young
1 37 9 Cheek +
2 38 9 Shoulder
3 37 9 Nose +
4 20 9 Lip - -
5 39 9 Lip ++ -
6 31 CT Scalp
7 31 9 Scalp
8 38 d Cheek +
9 33 d Nose +
10 31 d Temple +
Old
1 78 9 Nose +++ + +
2 69 Is Temple + ++
3 73 9 Nose + + + +
4 76 d Arm +++ +++
5 81 9 Lip +++-
6 70 9 Lip +++ ++
7 81 d Neck +++ +++
8 73 d Temple +++ +++
9 75 d Scalp + + +++
10 90 d Scalp ++++
Human skin samples from the indicated donors and sites were
sectioned and stained. For each sample, at least five sections were
viewed in a blinded fashion and assessed for SA-,-Gal. -, No staining;
±, one positive cell; +, two to four positive cells; + +, several positive
cells in the dermis, clusters in the epidermis; + + +, positive cells in all
sections of dermis, multiple clusters in all sections of epidermis (see
Fig. 3).
positive dermal staining (Table 2). In the epidermis, SA-f-
Gal-positive cells were in the basal layers, randomly distributed
in some sections, clustered in others. The upper differentiated
layers were negative. About half of the young donors showed
some epidermal staining, typically in one or a few cells. One
young donor sample was from obviously sun-damaged skin yet
was devoid of staining (Fig. 3D). By contrast, SA-,B-Gal-
positive cells were always seen in the epidermis of old donors.
Two old donors had staining in isolated cells; the remainder
had clusters of positive cells (Fig. 3 G and H).
DISCUSSION
SA-j8-Gal and Senescence. Cells from all three embryonic
layers expressed SA-,B-Gal upon senescence in culture. Still,
some cells-adult melanocytes and sebaceous and eccrine
gland cells-expressed the activity independent of senescence
or age. In addition, we have not detected SA-,B-Gal in senes-
cent fibroblasts from two mouse strains, although senescent rat
fibroblasts were positive. Thus, SA-,B-Gal is not a universal
marker of replicative senescence, which is not surprising. The
age- or senescence-independent expression by some cells
suggests that induction in otherwise nonexpressing cells may
reflect senescence-associated changes in differentiation (see
ref. 4). SA-,B-Gal must have cell-specific functions, and its
induction upon senescence may be limited to certain cell types.
Nonetheless, SA-,B-Gal was a good marker of senescence in
some human cells. Moreover, its induction depended on
replicative or physiologic age, suggesting that it could serve as
a biomarker of aging. We suggest that the age-dependent rise
in SA-P-Gal in human skin reflects an accumulation of senes-
cent fibroblasts and keratinocytes in vivo.
Origin and Function. We do not yet know the origin or
function of SA-13-Gal. A neutral ,3-Gal activity has been
described in mammalian tissues (27). Senescence might entail
9366 Cell Biology: Dimri et al.
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the induction of this or a related enzyme. Alternatively,
because some lysosome activities are elevated in senescent
cells (28, 29), lysosomal (3-Gal may increase such that its
activity is detectable at pH 6. Senescent cells might also express
the alternately spliced (short) form of lysosomal (3-Gal (25),
which may encode pH 6 activity, or localization might alter the
lysosomal ,3-Gal pH optimum. Preliminary data (G.P.D., B.
Huang, and J.C., unpublished) favor the second possibility. In
situ staining, which is not quantitative, showed little difference
between presenescent and senescent cells at pH 4, but soluble
assays showed 5- to 10-fold more pH 4 activity in senescent
cells. The pH vs. activity profile was too broad to discern a
distinct pH 6 peak. Senescent cells also expressed 3- to 5-fold
more lysosomal /3-Gal mRNA. Finally, when the long-form,
but not short-form, cDNA was overexpressed in SA-/3-Gal-
negative cells, staining was detectable at pH 6. These data are
consistent with lysosomal /B-Gal overexpression giving rise, at
least in part, to the activity in senescent cells.
It is unlikely that SA-,B-Gal causes the growth arrest of
senescent cells. Indeed, cells positive for SA-,B-Gal and
[3H]thymidine were consistently, albeit infrequently, observed.
SA-/3-Gal most likely reflects the change in cell function that
invariably accompanies senescence.
Senescence Genes and Pathology. SA-j3-Gal provides a
simple assay for chromosomes that induce senescence and
should facilitate the cloning of senescence genes. It also
provides in situ evidence that senescent cells may accumulate
in vivo at sites that show age-related pathology. Dermal
thinning and collagen breakdown are hallmarks of aging skin
that may be due to senescent fibroblasts, which overexpress
collagenase and underexpress collagenase inhibitors (30). Sim-
ilarly, endothelial cells lining vessels subject to hemodynamic
stress may senesce early in life (C. Harley and M.L., unpub-
lished). The altered functions of senescent endothelial cells
(31) may initiate or exacerbate atherosclerosis. Further studies
are now needed to determine how SA-,B-Gal relates to other
physiologic signs of age and to show that senescent cells indeed
contribute to age-related pathology. A biomarker for replica-
tive senescence should facilitate these studies.
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